HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.

Abstract
Approximately 500,000 people are hospitalized with severe dengue illness annually. Antibody-dependent enhancement (ADE) of dengue virus (DENV) infection is believed to contribute to the pathogenic cytokine storm described in severe dengue patients, but the precise signaling pathways contributing to elevated cytokine production are not elucidated. IL-1β is a potent inflammatory cytokine that is frequently elevated during severe dengue, and the unique dual regulation of IL-1β provides an informative model to study ADE-induced cytokines. This work utilizes patient-derived anti-DENV mAbs and primary human monocytes to study ADE-induced IL-1β and other cytokines. ADE of DENV serotype 2 (DENV-2) elevates mature IL-1β secretion by monocytes independent of DENV replication by 4 h postinoculation (hpi). Prior to this, DENV immune complexes activate spleen tyrosine kinase (Syk) within 1 hpi. Syk induces elevated IL1B, TNF, and IL6 mRNA by 2 hpi. Syk mediates elevated IL-1β secretion by activating ERK1/2, and both Syk and ERK1/2 inhibitors ablated ADE-induced IL-1β secretion. Maturation of pro-IL-1β during ADE requires caspase-1 and NLRP3, but caspase-1 is suboptimally increased by ADE and can be significantly enhanced by a typical inflammasome agonist, ATP. Importantly, this inflammatory Syk-ERK signaling axis requires DENV immune complexes, because DENV-2 in the presence of serotype-matched anti-DENV-2 mAb, but not anti-DENV-1 mAb, activates Syk, ERK, and IL-1β secretion. This study provides evidence that DENV-2 immune complexes activate Syk to mediate elevated expression of inflammatory cytokines. Syk and ERK may serve as new therapeutic targets for interfering with ADE-induced cytokine expression during severe dengue.
AuthorsJustin B Callaway, Scott A Smith, Karen P McKinnon, Aravinda M de Silva, James E Crowe Jr, Jenny P-Y Ting
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 290 Issue 28 Pg. 17306-20 (Jul 10 2015) ISSN: 1083-351X [Electronic] United States
PMID26032420 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Antibodies, Viral
  • Antigen-Antibody Complex
  • Carrier Proteins
  • Interleukin-1beta
  • Intracellular Signaling Peptides and Proteins
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • RNA, Messenger
  • RNA, Small Interfering
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
  • Caspase 1
  • Glyburide
Topics
  • Antibodies, Viral (metabolism)
  • Antibody-Dependent Enhancement
  • Antigen-Antibody Complex (metabolism)
  • Carrier Proteins (antagonists & inhibitors, genetics, metabolism)
  • Caspase 1 (metabolism)
  • Cells, Cultured
  • Dengue (genetics, immunology, virology)
  • Dengue Virus (immunology, pathogenicity, physiology)
  • Glyburide (pharmacology)
  • Humans
  • Interleukin-1beta (biosynthesis, genetics)
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • MAP Kinase Signaling System
  • Monocytes (enzymology, immunology, virology)
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Protein-Tyrosine Kinases (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • Syk Kinase
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: